JPMA Establishes Work Group To Consider Information Disclosure Rule
This article was originally published in PharmAsia News
Executive Summary
The Japanese Pharmaceutical Manufacturer's Association June 17 established a work group to discuss rules for disclosing funds provided to medical researchers from drug companies. The association hopes to gather information from overseas and decide on the range and scope of such financial provisions and establish industry-wide policy guidance. JPMA aims to summarize various opinions by the fall. The financial information disclosure guidance intends to address fairness and objectivity issues regarding medical researchers. An April survey conducted by Yomiuri Shimbun of the JMPA's 69 members found that only 10 percent expressed their willingness to disclose the information. (Click here for more - Japanese language